Vivera Pharmaceuticals, Inc. is an innovative, science-driven pharmaceutical company focused on opioid deterrence and cessation and non-addictive solutions for pain management.

In addition to its pharmaceutical and medical device products, the Company has global exclusivity to license the patented and provisionally patented, TABMELT® sublingual drug-delivery system for pharmaceutical use.

Vivera Pharmaceuticals is seeking to conduct case studies and clinical trials utilizing the TABMELT drug delivery format.

With multiple divisions, Vivera is vertically integrated with patented technology, manufacturing capabilities, and distribution for its products.